SCHEMBL5744596

SCHEMBL5744596

Cc1cc(C(CN)c2ccc3ccccc3n2)cc2cn(COCC[Si](C)(C)C)nc12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746426 0.87 PDE10A (0.32) —
SCHEMBL5745800 0.86 DGAT1 (0.32) —
SCHEMBL5744724 0.85 BRD4 (0.32) —
SCHEMBL5746467 0.85 ALOX5 (0.31) ALOX5
SCHEMBL5744915 0.85 DGAT1 (0.32) —
SCHEMBL4498155 0.82 CALCRL (0.30) —
SCHEMBL5744102 0.77 — —
SCHEMBL5746562 0.77 DGAT1 (0.34) —
SCHEMBL5745667 0.76 BRD4 (0.34) —
SCHEMBL5743215 0.76 DGAT1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689738-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS Bristol-Myers Squibb Company (US) 2006-08-16 — — EP disclosed
WO-2005056550-A2 HETEROCYCLIC ANTI-MIGRAINE AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-23 — — WO disclosed
Send feedback